Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-001612
Filing Date
2025-01-06
Accepted
2025-01-06 06:01:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3063
  Complete submission text file 0000950170-25-001612.txt   4479
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Subject) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40671 | Film No.: 25508916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Miller Deborah Ann (Reporting) CIK: 0001868741 (see all company filings)

Type: 144